Owens & Minor (NYSE:OMI – Get Rating) had its target price decreased by equities researchers at Citigroup from $58.00 to $52.00 in a research report issued to clients and investors on Thursday, The Fly reports. Citigroup’s target price would indicate a potential upside of 58.97% from the company’s current price.
Separately, StockNews.com downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a research report on Wednesday, May 11th. Two investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $50.33.
Owens & Minor Stock Up 0.1 %
Shares of NYSE OMI opened at $32.71 on Thursday. The company has a debt-to-equity ratio of 2.68, a quick ratio of 0.67 and a current ratio of 1.55. Owens & Minor has a 52-week low of $29.50 and a 52-week high of $49.11. The company’s 50 day moving average price is $32.97 and its 200-day moving average price is $38.02. The company has a market capitalization of $2.49 billion, a P/E ratio of 16.19, a price-to-earnings-growth ratio of 1.32 and a beta of 0.55.
Insiders Place Their Bets
In other Owens & Minor news, Director Gwendolyn M. Bingham sold 7,600 shares of the company’s stock in a transaction on Thursday, May 12th. The shares were sold at an average price of $35.32, for a total transaction of $268,432.00. Following the transaction, the director now owns 22,184 shares in the company, valued at $783,538.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Owens & Minor news, Director Gwendolyn M. Bingham sold 7,600 shares of the company’s stock in a transaction on Thursday, May 12th. The shares were sold at an average price of $35.32, for a total transaction of $268,432.00. Following the transaction, the director now owns 22,184 shares in the company, valued at $783,538.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Jeffrey T. Jochims sold 8,000 shares of the company’s stock in a transaction on Friday, July 1st. The stock was sold at an average price of $31.31, for a total transaction of $250,480.00. Following the transaction, the chief operating officer now owns 195,956 shares in the company, valued at approximately $6,135,382.36. The disclosure for this sale can be found here. Corporate insiders own 4.09% of the company’s stock.
Institutional Trading of Owens & Minor
Several institutional investors have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Owens & Minor in the 2nd quarter worth $359,000. TD Asset Management Inc. bought a new stake in shares of Owens & Minor in the 2nd quarter worth $258,000. Jackson Creek Investment Advisors LLC bought a new stake in shares of Owens & Minor in the 2nd quarter worth $912,000. AE Wealth Management LLC grew its stake in shares of Owens & Minor by 60.0% in the 2nd quarter. AE Wealth Management LLC now owns 10,799 shares of the company’s stock worth $340,000 after acquiring an additional 4,051 shares in the last quarter. Finally, Wolverine Asset Management LLC grew its stake in shares of Owens & Minor by 39.2% in the 2nd quarter. Wolverine Asset Management LLC now owns 54,505 shares of the company’s stock worth $1,714,000 after acquiring an additional 15,362 shares in the last quarter. Institutional investors own 95.69% of the company’s stock.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
See Also
- Get a free copy of the StockNews.com research report on Owens & Minor (OMI)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.